Ozdemir Ozcan, Leung Andrew, Bussiére Miguel, Hachinski Vladimir, Pelz David
Department of Clinical Neurological Sciences, University of Western Ontario, London Health Sciences, University Campus, London, Ontario, Canada.
Stroke. 2008 Jul;39(7):2011-6. doi: 10.1161/STROKEAHA.107.505230. Epub 2008 May 1.
The hyperdense middle cerebral artery sign (HMCAS) is a well-established marker of early ischemia on noncontrast computed tomography of the brain (NCCT). Recently the MCA dot sign has been described and proposed to indicate thrombosis of the M2 or M3 middle cerebral artery branches. The purpose of this study was to define the hyperdense ICA sign (HICAS) and determine its prevalence, diagnostic and prognostic value, and its reliability as a marker for ischemia.
Noncontrast computed tomography scans of 71 patients with acute ischemic stroke were analyzed for the presence of a HICAS, HMCAS, or MCA dot sign. For the validation of HICA and HMCA signs on NCCT, 32 of 71 patients who underwent gold standard CT angiography (CTA) before thrombolytic therapy were included in the analysis. The presence of a HICAS was correlated with initial neurological severity and the short and long-term outcomes.
A HICAS was found in 24% of patients on NCCT. In patients with a HICAS, mean age was 63+/-17.4 and mean time from symptom onset to CT was 103 minutes. Interobserver agreement was excellent for the HICAS. The HICAS has high specificity (100%) and positive predictive value (100%) in predicting the presence of distal internal carotid artery thrombus on CTA. Patients with a HICAS had a more severe initial neurological deficit and worse prognosis than patients without a HICAS.
The HICAS is a reliable and a highly specific marker of thromboembolic occlusion of the distal ICA and is associated with severe initial neurological deficit and worse outcome despite thrombolytic therapy.
大脑中动脉高密度征(HMCAS)是脑部非增强计算机断层扫描(NCCT)上早期缺血的一个公认标志。最近,大脑中动脉点状征已被描述并提出用于指示大脑中动脉M2或M3分支的血栓形成。本研究的目的是定义颈内动脉高密度征(HICAS),并确定其发生率、诊断和预后价值,以及作为缺血标志物的可靠性。
对71例急性缺血性卒中患者的NCCT扫描进行分析,以确定是否存在HICAS、HMCAS或大脑中动脉点状征。为了在NCCT上验证HICA和HMCA征,71例在溶栓治疗前行金标准CT血管造影(CTA)的患者中有32例纳入分析。HICAS的存在与初始神经功能严重程度以及短期和长期预后相关。
在NCCT上,24%的患者发现有HICAS。有HICAS的患者,平均年龄为63±17.4岁,从症状发作到CT检查的平均时间为103分钟。观察者间对HICAS的一致性良好。HICAS在预测CTA上颈内动脉远端血栓存在方面具有高特异性(100%)和阳性预测值(100%)。有HICAS的患者比没有HICAS的患者初始神经功能缺损更严重,预后更差。
HICAS是颈内动脉远端血栓栓塞性闭塞的可靠且高度特异性的标志物,与初始严重神经功能缺损相关,且尽管进行了溶栓治疗,预后仍较差。